Europska Unija -
hrvatski -
EMA (European Medicines Agency)
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - cjepiva - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
Hrvatska -
hrvatski -
HALMED (Agencija za lijekove i medicinske proizvode)
naelia 0,06 mg/0,015 mg filmom obložene tablete
pliva hrvatska d.o.o., prilaz baruna filipovića 25, zagreb - gestoden etinilestradiol - filmom obložena tableta - 0,06 mg/0,015 mg - urbroj: jedna blijedožuta filmom obložena tableta sadrži 0,060 mg gestodena i 0,015 mg etinilestradiola; bijele tablete ne sadrže djelatne tvari (tablete s placebom)